Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia CorpfiledCriticalPharmacia Corp
Priority to CR7415ApriorityCriticalpatent/CR7415A/en
Publication of CR7415ApublicationCriticalpatent/CR7415A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se describen compuestos de la Formula I y sus sales farmaceuticamente aceptables, en los que R1, R2, R3, R4 y R5 se definen en la presente. Estos compuestos son utiles para tratar enfermedades y afecciones causadas o exacerbadas por la actividad de p38 MAP quinasa desregulada y/o FNT. Tambien se describen composiciones farmaceuticas que contienen los compuestos, metodos para preparar los compuestos y metodos de tratamiento que utilizan los compuestos.Compounds of Formula I and their pharmaceutically acceptable salts are described, wherein R1, R2, R3, R4 and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by the activity of deregulated p38 MAP kinase and / or FNT. Pharmaceutical compositions containing the compounds, methods for preparing the compounds and methods of treatment using the compounds are also described.
CR7415A2004-08-132004-08-13
PIRIDINONES REPLACED AS MODULATORS OF P38 MAP QUINASAS
CR7415A
(en)